Genomic & Biopharma News

Researchers uncover evidence linking mental health disorders and disturbances to gut microbiome
Better understanding the gastrointestinal microbiome may help psychiatrists treat mental health disorders such as depression, highlights a review in Frontiers in Psychiatry.
News Medical Life Sciences, 2017-08-23 17:24:08

Xellia completes $13M expansion of its Budapest facility
Xellia has completed a $13 million expansion at its facility in Budapest, Hungary, that will bolster the Danish API maker’s focus on anti-infective products.
Fierce Pharma, 2017-08-23 16:53:00

Antipsychotics commonly prescribed to adults with IDD, study finds
Antipsychotic medication is frequently being prescribed to individuals with intellectual and developmental disabilities (IDD), often without a psychiatric diagnosis, a new study conducted by the Centre for Addiction and Mental Health and Institute for Clinical Evaluative Sciences has found.
News Medical Life Sciences, 2017-08-23 16:44:57

Study finds excessive mortality in people with extremely high levels of good cholesterol
It has been accepted wisdom for many years that the more good cholesterol people have in their blood, the better. But the good cholesterol, also known as HDL, might not be as good as we think.
News Medical Life Sciences, 2017-08-23 16:32:00

Opinion: Science, Meet Politics
The events of the past six months have inspired advocacy for the first time.
The Scientist, 2017-08-23 16:17:00

Study findings could one day help doctors better predict survival of liver cancer patients
A new study of a molecule that regulates liver-cell metabolism and suppresses liver-cancer development shows that the molecule interacts with thousands of genes in liver cells, and that when levels of the molecule go down, which often happens during liver-cancer development, the activity of certain cancer-promoting genes goes up.
News Medical Life Sciences, 2017-08-23 15:47:31

Blood cleaning device can also effectively provide a bridge to liver transplantation
Severe acute liver failure (ALF), a rare but life-threatening illness, is associated with high death rates if patients don't receive timely treatment or a liver transplant.
News Medical Life Sciences, 2017-08-23 15:38:42

No need for 60%-plus discounts on Repatha, Amgen says, rolling out real-world data as backup
Amgen has rolled out a new economic analysis of Repatha’s outcomes study, Fourier, which initially failed to wow the market when unveiled earlier this year. The gist? The PCSK9 drug is cost-effective at $9,669 per year or less, almost $5,000 off its list price.
Fierce Pharma, 2017-08-23 15:35:20

News of Note—Stryker falls on Sage Products recall; Tandem improves refill process for insulin infusion set
Here's this week's medtech news of note.
Fierce Biotech, 2017-08-23 15:21:17